论文部分内容阅读
通过造血组织恶性细胞培养(26例),证明AML(9例)的CFU-C以生长差为特点,形态学上簇或集落内以幼稚细胞占优势;而非白血病对照 (12例) 则以成熟细胞占优势。2例完全缓解的AML的CFU-C类似对照;3例白前中2例(已确诊)CFU-C类似AML,另1例高度疑为白前者CFU-C符合白前。因此,本研究对白血病的疗效评价、预后判断及早期诊断均有参考阶值。
Through the hematopoietic tissue culture of malignant cells (26 cases), CFU-C of AML (9 cases) was characterized by poor growth, morphologically clusters or colony dominated by naive cells; non-leukemia control (12 cases) Mature cells are dominant. Two cases of CFU-C with complete remission (AML) were similar; three cases of pre-white anterior (CFU-C) -like AML, and the other a case of highly suspected white former CFU-C. Therefore, the study of leukemia efficacy evaluation, prognosis and early diagnosis have reference rank.